Osaic Holdings’s Psyence Biomedical PBM Stock Holding History

Osaic Holdings’s Portfolio PBM Stock Details PBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-720	Closed	-$14.4K	–	8236
2025 Q3	$14.4K	Buy	+720	New	+$19.8K	﹤0.01%	6142

Other funds holding PBM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

Osaic Holdings's PBM Position: Q4 2025 in Review

Osaic Holdings sold out of Psyence Biomedical (PBM) in Q4 2025, closing a stake of 720 shares — an estimated $14.4K sold.

Osaic Holdings first reported a position in PBM in Q3 2025 and held it in 1 quarter. The position peaked at $14.4K in Q3 2025. 5 funds tracked by Wall St. Rank hold PBM as of Q4 2025.

Osaic Holdings reported no remaining Psyence Biomedical position as of Q4 2025 after selling out during the quarter.
Osaic Holdings sold 720 Psyence Biomedical shares in Q4 2025, an estimated $14.4K.
Osaic Holdings first reported a position in Psyence Biomedical in Q3 2025 and held it in 1 quarter.
Osaic Holdings's Psyence Biomedical position peaked at $14.4K in Q3 2025.
5 funds tracked by Wall St. Rank held Psyence Biomedical as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.